Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek N Middlemiss

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Opinion in Pharmacology|January 12, 2002
Serotonergic targets in depressionDerek N Middlemiss, Gary W Price, Jeannette M Watson
Progress in Medicinal Chemistry|May 31, 2003
The discovery and development of 5-HT-terminal autoreceptor antagonistsJohn W Clitherow, Frank D King, Derek N Middlemiss, et al.
Synapse (New York, N.Y.)|September 27, 2002
Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell studyThomas P Blackburn, Yoshio Minabe, Derek N Middlemiss, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 6, 2002
Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in ratsStanislav R Vorel, Charles R Ashby, Mousumi Paul, et al.
European Journal of Pharmacology|March 3, 2005
Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodoneZoë A Hughes, Kathryn R Starr, Christopher J Langmead, et al.
British Journal of Pharmacology|June 19, 2003
SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in ratsDavid R Thomas, Sergio Melotto, Mario Massagrande, et al.
Journal of Medicinal Chemistry|October 31, 2003
Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonistGregor J Macdonald, Clive L Branch, Michael S Hadley, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2005
8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligandsTom D Heightman, Laramie M Gaster, Sarah L Pardoe, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
3,4-Dihydro-2H-benzoxazinones are 5-HT(1A) receptor antagonists with potent 5-HT reuptake inhibitory activityPeter J Atkinson, Steven M Bromidge, Mark S Duxon, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Pharmacology|January 12, 2002
Serotonergic targets in depressionDerek N Middlemiss, Gary W Price, Jeannette M Watson
Progress in Medicinal Chemistry|May 31, 2003
The discovery and development of 5-HT-terminal autoreceptor antagonistsJohn W Clitherow, Frank D King, Derek N Middlemiss, et al.
Synapse (New York, N.Y.)|September 27, 2002
Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell studyThomas P Blackburn, Yoshio Minabe, Derek N Middlemiss, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 6, 2002
Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in ratsStanislav R Vorel, Charles R Ashby, Mousumi Paul, et al.
European Journal of Pharmacology|March 3, 2005
Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodoneZoë A Hughes, Kathryn R Starr, Christopher J Langmead, et al.
British Journal of Pharmacology|June 19, 2003
SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in ratsDavid R Thomas, Sergio Melotto, Mario Massagrande, et al.
Journal of Medicinal Chemistry|October 31, 2003
Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonistGregor J Macdonald, Clive L Branch, Michael S Hadley, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2005
8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligandsTom D Heightman, Laramie M Gaster, Sarah L Pardoe, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
3,4-Dihydro-2H-benzoxazinones are 5-HT(1A) receptor antagonists with potent 5-HT reuptake inhibitory activityPeter J Atkinson, Steven M Bromidge, Mark S Duxon, et al.
Pageof 1